Partnering
Biothera is seeking licensees and collaborative Research & Development agreements for the commercialization of Imprime PGG in combination with:
- Anti-tumor monoclonal antibodies for the treatment of various cancers.
- Growth factors for enhancing hematopoietic activity.
- Antibiotics for the treatment of infectious disease.
Contact:
Daniel K. Conners
Chairman and Founder
[President, Pharmaceutical Group]
651-675-0300